Visit the original URL
On July 23, at the press conference of the Joint Prevention and Control Mechanism of the State Council, Wang Fusheng, director of the Department of Infectious Diseases of the Fifth Medical Center of the People’s Liberation Army General Hospital, said that a large amount of research evidence at home and abroad shows that the new crown vaccine is effective in preventing morbidity, severe illness and death. The effect is very significant, and booster immunization can further improve the protection effect. Recently, the outbreaks in Hong Kong and Shanghai were mainly caused by Omicron. The study found that for 18-59-year-old infected people who completed the full course of vaccination and booster vaccination, the risk of developing from mild to common is 63% and 65% lower than that of unvaccinated infected persons, and the risk of developing from common and below to severe. 91% and 94% lower; for infected persons over 60 who have completed full vaccination and booster vaccination, the risk of developing from mild to common is 73% and 82% lower than that of unvaccinated infected persons, and from common and below to common The risk of severe illness is 89% and 95% lower than in unvaccinated infected people. This is also in full compliance with the standards set by the World Health Organization for the new coronavirus vaccine, which is to prevent infection, prevent severe illness, and prevent death. (CCTV News)
- Joint Prevention and Control Mechanism of the State Council: The effect of the new crown vaccine on disease prevention, severe disease prevention and death prevention is very significant 2022-07-23
- Multi-country real-world data confirms that vaccines can reduce mortality by the highest or even dozens of times 2022-01-21
- WeChat Souyisou launched a new crown vaccine appointment service, supporting online one-click appointments in more than 45 cities2021-03-25
- Sinopharm’s new crown vaccine is open for appointment in Beijing and Wuhan2020-10-12
This article is reprinted from: https://readhub.cn/topic/8hSWCYMmDfQ
This site is for inclusion only, and the copyright belongs to the original author.